Hermann et al. have shown that the expression of CD133 in freshly isolated primary human pancreatic cancer cells can be used to identify cells with the capacity of self-renewal, sphere formation, and most importantly, in vivo tumorigenesis [18]. The gene discussed is PROM1; the disease is familial pancreatic carcinoma.